Fed. Circ. Weighs In On Obviousness-Type Double Patenting

By Chad Peterman, Mi Zhou and Hyosang (Mark) Kim
June 4, 2018, 4:27 PM EDT

In a recent split decision in UCB v. Accord, the Federal Circuit affirmed a finding that claims covering a pharmaceutical compound were not invalid for obviousness-type double patenting, or OTDP.[1] The...

Already a subscriber? Click here to view full article